Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

915
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
915
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

3
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
3
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

3
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

1
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
1

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biomarkers for congestion assessment and prognosis in acute heart failure: A systematic review.

Experimental and molecular pathology·2026
Same author

Contrast Media Side Effects and Kounis Syndrome: Timeo Danaos et Dona Ferentes.

Balkan medical journal·2026
Same author

Kounis Syndrome Features in Special Populations.

Medical sciences (Basel, Switzerland)·2026
Same author

Atherosclerosis features in rheumatic diseases - focus on peripheral artery disease.

Frontiers in immunology·2026
Same author

The Nutritional Paradox of Obesity: Mechanisms and Clinical Implications of Micronutrient Deficiencies.

Medical sciences (Basel, Switzerland)·2026
Same author

Influence of Phenotypes on Short-Term Outcomes in Hospitalized Heart Failure with Preserved Ejection Fraction-Insights from a North-Eastern Romanian Cohort.

Medical sciences (Basel, Switzerland)·2026

相关实验视频

Updated: Jun 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

阿米奥达龙治疗:更新的实用洞察力

Victorița Șorodoc1,2, Lucia Indrei3, Catinca Dobroghii1

  • 1Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.

Journal of clinical medicine
|October 26, 2024
PubMed
概括

阿米奥达龙是一种有效的抗心律失常药物,有效治疗心房动和心室心律失常. 其复杂的药理动力学和潜在的副作用需要仔细管理和监测,以获得最佳的患者结果.

关键词:
延长了QT的时间一个朋友,一个朋友,一个朋友.艾米奥达龙诱导的甲状腺功能低下症艾米奥达龙诱导的角质病变艾米奥达龙诱导的肺毒性艾米奥达龙诱导的甲状腺毒性心房动是心房动的一种.蓝灰综合征是什么意思 蓝灰综合征腹腔动脉动是一种心房动.腹腔动脉短心症是什么意思

更多相关视频

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

391
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

相关实验视频

Last Updated: Jun 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

391
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 心脏病学 心脏病学
  • 内部医学 内部医学

背景情况:

  • 阿米奥达龙是一种广泛使用的抗心律失常药物.
  • 它表现出所有四个沃恩·威廉姆斯抗节律失常类别的特性.
  • 有效治疗心房和心室心律不整.

研究的目的:

  • 为提供关于阿米奥达龙的全面审查.
  • 涵盖指示,禁忌和剂量.
  • 详细介绍药物相互作用,副作用和监测.

主要方法:

  • 对阿米奥达龙的特性进行文献综述.
  • 对药理动力学和药理动力学数据的分析.
  • 临床试验和观察数据的综合.

主要成果:

  • 阿米奥达龙显示出广泛的抗心律失常疗效.
  • 复杂的药理动力学,半衰期长.
  • 潜在的显著副作用和药物相互作用.

结论:

  • 艾米奥达龙需要充分了解安全和有效的使用.
  • 谨慎的剂量调整和监测至关重要.
  • 对副作用和相互作用的管理对于患者的安全至关重要.